AstraZeneca said its COVID-19 vaccine is safe and effective following an interim analysis of data from a U.S.-based Phase 3 trial involving more than 32,000 participants.
“The vaccine was well tolerated, and the independent data safety monitoring board (DSMB) identified no safety concerns related to the vaccine,” the company said in a March 22 statement.
